HLA-DRA has been studied in cervical cancer [55,56], low-grade gliomas [57], renal clear cell carcinoma [58], pediatric adrenocortical tumors [59], non-small cell lung cancer [60], and breast cancer [61]. Here, HLA-DRA is linked to cervical carcinoma.